Symptoms of Factor V Leiden
Most individuals with Factor V Leiden remain completely asymptomatic throughout their lives, as this is a low-penetrance genetic mutation—only about 10% of heterozygotes and up to 80% of homozygotes will ever develop venous thromboembolism (VTE) in their lifetime 1.
Primary Clinical Manifestations
When symptoms do occur, they manifest as venous thrombotic events, not as a distinct symptom complex:
Venous Thromboembolism (Most Common)
- Deep vein thrombosis (DVT) - typically in the legs, presenting with leg pain, swelling, warmth, and skin changes 2, 3
- Pulmonary embolism (PE) - chest pain, shortness of breath, hemoptysis, and potentially sudden death 3
- Unusual site thrombosis - hepatic veins, mesenteric veins, cerebral venous sinuses 1
The first lifetime episode of VTE in Factor V Leiden carriers typically occurs after age 50, though it can present at any age 1.
Pregnancy-Related Complications (Women)
Factor V Leiden increases risk for 1:
- Recurrent pregnancy loss (particularly late-trimester)
- Severe preeclampsia
- Placental abruption
- Intrauterine fetal growth retardation
- Stillbirth
Post-Thrombotic Syndrome (Long-term Sequela)
Following DVT, patients may develop 3:
- Chronic leg pain
- Skin changes and discoloration
- Leg swelling
- Venous ulcers (severe cases)
- Cumulative incidence: 23% at 2 years, 28% at 5 years
Important Clinical Context
Factor V Leiden does NOT typically cause arterial thrombosis, myocardial infarction, or stroke 1. The notable exception is myocardial infarction in young female smokers under age 45-50, where the combination increases relative risk 32-fold 1.
Risk Stratification by Genotype
- Heterozygotes (one copy): ~10% lifetime VTE risk, 4-7 fold increased risk over baseline 1, 3
- Homozygotes (two copies): >80% lifetime VTE risk, 9-80 fold increased risk 1
- Compound heterozygotes (Factor V Leiden + Prothrombin G20210A): 20-fold increased risk 1, 3
Triggering Factors That Unmask the Mutation
Symptoms typically emerge when genetic predisposition combines with environmental triggers 1:
- Oral contraceptive use
- Pregnancy and postpartum period (6-8 weeks)
- Surgery or trauma
- Prolonged immobilization
- Malignancy
- Advanced age
Critical Clinical Pitfall
The absence of symptoms does NOT exclude Factor V Leiden. This is an adult-onset disorder of low penetrance, meaning most carriers never develop clinical manifestations 1. Testing asymptomatic individuals is generally not recommended except in specific high-risk scenarios (family members of young VTE patients, women considering oral contraceptives with strong family history) 1.
The key clinical point: Factor V Leiden itself produces no symptoms—it only increases the risk of developing venous blood clots, which then produce symptoms based on their location and severity.